Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBV5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,621
Award facts
- Contract value 100% obligated
- $43,621.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $43.6K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 200-unit vials of BOTOX. The delivery order, issued on January 8, 2026, with an ultimate completion date of January 30, 2026, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and deliver the product to support Department of Defense medical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded in November 2025 with a $500M ceiling value and term extending through December 2036. The PPV-G GEN V program represents part of a $30.3B Defense Logistics Agency acquisition strategy designed to ensure reliable pharmaceutical supply chains supporting military healthcare facilities worldwide. As a prime vendor contractor under this vehicle, DMS Pharmaceutical Group has demonstrated consistent performance delivering a comprehensive portfolio of pharmaceuticals and medical consumables, from routine medications to specialty biologics and high-cost oncology treatments, positioning the company as a critical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FFBV5?
SPE2DR26FFBV5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FFBV5 worth?
The government has obligated $43,621 on SPE2DR26FFBV5.
Is contract SPE2DR26FFBV5 an order under another contract?
Yes. SPE2DR26FFBV5 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBV5 competed?
The extent of competition for SPE2DR26FFBV5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award